Plain-English translation of NCT07247084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing , a new injectable medication given once a week, to see if it helps people with obesity lose weight and prevent type 2 diabetes. Researchers want to understand how well this treatment works in real-world conditions — not just in a controlled lab setting. The trial will follow participants for about 5 years to track weight loss and health outcomes.
Obesity is a serious health condition that increases the risk of type 2 diabetes and other complications. Current standard weight loss treatments don't work well enough for many people, so researchers are testing whether this medication can provide better results and help prevent diabetes from developing.
You likely qualify if…
You likely don't qualify if…
If you're randomly assigned to receive the medication, you'll give yourself an injection under the skin once a week, along with following standard weight loss advice like diet and exercise. The other group will receive standard care alone without the new medication. You'll attend regular clinic visits over the 5-year study period so the research team can monitor your weight, health, and any side effects. Blood tests may be done to check for diabetes development and overall health.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United Kingdom